V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007693 | 330004523 | 1.66 | 107 | Curative (C) | 2018-01-12 | 2018-02-23 | Paclitaxel 7 day | 2 | N | 330012345 | PACLITAXEL |
| 330007694 | 330004525 | 1.77 | 73.6 | Adjuvant (A) | null | 2014-11-18 | VAI (Ifos 3g/m2) | N | N | 330012347 | VAI |
| 330007695 | 330004527 | 1.62 | 145.4 | Curative (C) | 2016-01-17 | 2016-02-01 | VAI (Ifos 3g/m2) | N | N | 330012351 | VAI |
| 330007696 | 330004528 | null | null | Curative (C) | 2014-03-04 | 2014-03-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330012351 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007697 | 330008468 | 1.73 | 78 | Adjuvant (A) | 2015-11-24 | 2015-12-09 | CARBOPLATIN + ETOPOSIDE | N | N | 330012352 | CARBOPLATIN + ETOPOSIDE |
| 330007698 | 330004530 | 1.67 | 84.2 | Neo-adjuvant (N) | 2013-03-01 | 2013-03-15 | EURAMOS TRIAL | N | Y | 330012357 | EURAMOS TRIAL |
| 330007699 | 330004532 | 1.8 | 63.3 | Adjuvant (A) | 2013-12-28 | 2014-01-11 | ALL UKALL2011 Ind A Std Dex (PAsp) | null | N | 330012358 | UKALL2011 |
| 330007700 | 330004533 | null | 66 | Curative (C) | 2013-10-03 | 2013-10-29 | Bendamustine+Rituximab(Sub Courses) | 2 | null | 330012360 | BENDAMUSTINE + RITUXIMAB |
| 330007701 | 330008470 | 1.5 | 16.4 | Curative (C) | 2013-10-24 | 2013-12-02 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012360 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007702 | 330004535 | 1.71 | null | Curative (C) | 2018-06-07 | 2018-06-07 | Carboplatin + Etoposide iv&po | N | N | 330012373 | CARBOPLATIN + ETOPOSIDE |
| 330007703 | 330004537 | null | 112 | Curative (C) | 2014-09-19 | 2014-10-07 | CARBOPLATIN + ETOPOSIDE | Y | null | 330012373 | CARBOPLATIN + ETOPOSIDE |
| 330007704 | 330004537 | 1.75 | 21 | Curative (C) | null | 2017-03-29 | ALL UKALL2011 Del Int C Recon PAsp | N | null | 330012373 | UKALL2011 |
| 330007705 | 330010588 | 1.57 | 35 | Curative (C) | 2017-04-26 | 2017-09-16 | CARBOPLATIN + RT | N | N | 330012378 | CARBOPLATIN + RT |
| 330007706 | 330004541 | null | 63.1 | Neo-adjuvant (N) | 2013-10-11 | 2014-04-12 | BENDAMUSTINE + RITUXIMAB | null | N | 330012379 | BENDAMUSTINE + RITUXIMAB |
| 330007707 | 330004543 | 1.53 | 59.2 | Curative (C) | 2014-08-12 | 2014-08-12 | ALL UKALL2011 Std Int Maint A | N | null | 330012388 | UKALL2011 |
| 330007708 | 330004544 | 1.69 | 0 | Adjuvant (A) | 2014-11-03 | 2014-11-07 | CARBOPLATIN + ETOPOSIDE | N | N | 330012393 | CARBOPLATIN + ETOPOSIDE |
| 330007709 | 330004545 | 1.59 | null | Neo-adjuvant (N) | 2014-07-25 | 2014-09-09 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 330012393 | PACLITAXEL |
| 330007710 | 330004546 | 1.74 | 100 | Curative (C) | 2013-06-28 | 2013-07-06 | CARBOPLATIN + RT | N | N | 330012397 | CARBOPLATIN + RT |
| 330007711 | 330004547 | 1.7 | 103.5 | Curative (C) | 2013-10-04 | 2013-10-11 | Carboplatin + Etoposide iv&po | N | N | 330012410 | CARBOPLATIN + ETOPOSIDE |
| 330007712 | 330004547 | 1.72 | null | Curative (C) | 2017-03-17 | 2017-09-11 | Carboplatin + Etoposide iv&po | 2 | N | 330012410 | CARBOPLATIN + ETOPOSIDE |
| 330007713 | 330004549 | null | 97 | Palliative (P) | 2014-01-17 | 2014-01-28 | Paclitaxel 7 day | N | null | 330012411 | PACLITAXEL |
| 330007714 | 330004549 | 1.85 | 73.8 | Curative (C) | 2016-07-07 | 2016-07-17 | CARBOPLATIN + RT | 1 | N | 330012411 | CARBOPLATIN + RT |
| 330007715 | 330004549 | null | 47.5 | Curative (C) | 2014-09-12 | 2015-02-01 | CARBOPLATIN + RT | 2 | N | 330012411 | CARBOPLATIN + RT |
| 330007716 | 330004549 | 1.73 | 91 | Curative (C) | 2017-07-17 | 2017-09-16 | VAI (Ifos 3g/m2) | N | N | 330012411 | VAI |
| 330007717 | 330004549 | 1.7 | 76 | Neo-adjuvant (N) | 2015-01-02 | 2015-01-25 | CARBOPLATIN + ETOPOSIDE | N | N | 330012411 | CARBOPLATIN + ETOPOSIDE |
| 330007718 | 330004550 | 1.72 | 57.2 | Curative (C) | 2019-01-21 | 2019-01-21 | ALL UKALL2011 Maintenance A3 | 02 | N | 330012437 | UKALL2011 |
| 330007719 | 330004552 | 1.74 | 71 | Curative (C) | 2014-09-03 | 2014-09-24 | VAI (Ifos 3g/m2) | 2 | null | 330012441 | VAI |
| 330007721 | 330004554 | null | 78 | Neo-adjuvant (N) | 2017-09-04 | 2018-02-04 | Carboplatin+Fluorouracil 4 or 5 day | N | null | 330012450 | CARBO + FLUOROURACIL |
| 330007722 | 330004556 | 1.91 | 0 | Neo-adjuvant (N) | 2015-06-20 | 2015-06-20 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330012450 | CARBO + FLUOROURACIL |
| 330007723 | 330004557 | 1.72 | 19.7 | Adjuvant (A) | 2017-12-28 | 2017-12-28 | VAI (Ifos 3g/m2) | N | N | 330012452 | VAI |
| 330007724 | 330010593 | null | 68.3 | null | null | 2017-11-17 | CARBOPLATIN + ETOPOSIDE | null | null | 330012458 | CARBOPLATIN + ETOPOSIDE |
| 330007726 | 330004560 | 1.72 | 72 | Neo-adjuvant (N) | 2017-12-01 | 2017-12-15 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330012476 | CARBOPLATIN + PACLITAXEL |
| 330007727 | 330004561 | null | 54.6 | Palliative (P) | 2014-02-11 | 2014-02-12 | CARBOPLATIN + RT | 02 | N | 330012476 | CARBOPLATIN + RT |
| 330007728 | 330004561 | 1.56 | 51.7 | Neo-adjuvant (N) | null | 2017-04-08 | CARBOPLATIN + FLUOROURACIL | N | N | 330012476 | CARBO + FLUOROURACIL |
| 330007729 | 330004561 | 1.72 | 73.6 | Curative (C) | 2018-04-29 | 2018-04-29 | CARBOPLATIN + ETOPOSIDE | N | N | 330012476 | CARBOPLATIN + ETOPOSIDE |
| 330007730 | 330004561 | 1.71 | 88 | Disease modification (D) | 2015-08-16 | 2015-08-28 | CARBOPLATIN + ETOPOSIDE | 02 | N | 330012476 | CARBOPLATIN + ETOPOSIDE |
| 330007731 | 330004562 | 1.75 | 77 | Curative (C) | null | 2014-09-26 | ALL UKALL2011 (ProtM-A) C PegAsp | 02 | N | 330012495 | UKALL2011 |
| 330007732 | 330008488 | 1.76 | 91.9 | Neo-adjuvant (N) | 2014-11-14 | 2014-11-23 | Carbo F | 2 | N | 330012495 | CARBO + FLUOROURACIL |
| 330007733 | 330012437 | 1.59 | 48.5 | Neo-adjuvant (N) | null | 2013-12-19 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012502 | CARBOPLATIN + PACLITAXEL |
| 330007734 | 330004563 | 1.52 | null | Curative (C) | 2013-10-28 | 2013-11-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | null | 330012504 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007735 | 330008489 | null | 71 | null | 2017-04-30 | 2018-03-30 | Carboplatin + Etoposide IV 3 day | N | Y | 330012506 | CARBOPLATIN + ETOPOSIDE |
| 330007736 | 330004565 | 1.55 | 73.8 | Neo-adjuvant (N) | 2014-05-26 | 2014-10-27 | CARBOPLATIN + RT | N | N | 330012508 | CARBOPLATIN + RT |
| 330007737 | 330004565 | null | null | Adjuvant (A) | 2014-01-03 | 2014-01-03 | VAI (Ifos 3g/m2) | 02 | N | 330012508 | VAI |
| 330007738 | 330008491 | 1.61 | null | Neo-adjuvant (N) | 2014-08-05 | 2015-02-03 | EURAMOS TRIAL | Y | N | 330012515 | EURAMOS TRIAL |
| 330007739 | 330004567 | 1.59 | null | Palliative (P) | 2018-03-24 | 2018-03-24 | CarboPEC-Taxol | 02 | N | 330012518 | CARBOPLATIN + PACLITAXEL |
| 330007740 | 330004567 | 1.74 | 56.4 | null | 2013-05-03 | 2013-07-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012518 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007741 | 330004567 | null | 112 | Curative (C) | 2013-12-24 | 2014-01-30 | VAI (Ifos 3g/m2) | null | null | 330012518 | VAI |
| 330007742 | 330012438 | 1.73 | 21 | null | 2013-05-26 | 2014-07-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012532 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007743 | 330008493 | null | 64.7 | Curative (C) | 2017-03-18 | 2017-07-30 | EURAMOS TRIAL | N | N | 330012536 | EURAMOS TRIAL |
| 330007744 | 330004570 | 1.81 | 69.1 | Curative (C) | 2015-03-20 | 2015-04-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330012539 | CISPLATIN + DOCETAXEL + FLUOROURACIL |